Simple and efficacious inhalers
Inhalers based on Medspray's nozzle technology achieve a very high lung dose, up to 3 to 4 x more than conventional pMDIs or dry powder inhalers. By tailoring the droplet size and by controlling the inhalation air flow, the drug can be targeted to the upper lung (e.g. asthma bronchodilators), the central lung (e.g. antibiotic treatment), or for systemic uptake by the deep lung into the blood stream (e.g. migraine medication or nicotin delivery for smoking cessation)
Life cycle management
Drug delivery devices are the way forward to extend the product life cycle of pharma-ceutical prescribed and OTC products. From inhalers and nasal sprays to dermal & eye spray devices. This way a defendable market position can be build up, based on the device’s intellectual property, even if the formulation is becoming generic. A generic formulation in a new concentration or lower total dose (with the same local effect) may even enable you to acquire new product protection.